Rocket Pharmaceuticals RCKT SEC Filings

NASDAQ RCKT
$3.84 +0.05 (+1.19%)
As of: Sep 4, 2026 · 2:32 PM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Rocket Pharmaceuticals, Inc. (RCKT) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index